Pasithea Therapeutics Corp.
KTTA
$1.18
-$0.02-1.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.25% | 3.88% | 7.71% | 37.05% | 16.96% |
| Total Depreciation and Amortization | 11.89% | -0.37% | -0.37% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.05% | -66.53% | -90.78% | 124.79% | -67.23% |
| Change in Net Operating Assets | 71.42% | 28.43% | 133.57% | -68.64% | -485.76% |
| Cash from Operations | 7.39% | 4.21% | 29.28% | 37.45% | -17.55% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.56% | -- | -- | -- | -- |
| Cash from Financing | -102.56% | -- | -- | -- | 217.65% |
| Foreign Exchange rate Adjustments | 146.86% | 293.10% | -- | 806.45% | -530.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -314.80% | 146.41% | 63.41% | 25.06% | 119.73% |